Veea down 17.8% despite a governance-fix headline
Veea is the biggest mover on the list, down 17.8%, which sits oddly against the GuruFocus piece carried here. That article, dated October 8, describes a 49% after-hours jump after the company resolved all its Nasdaq listing compliance problems: Alan Black was added to the Compensation Committee, Kanishka Roy to the Audit Committee, and board member Helder Antunes resigned so independent directors would hold a majority, though he stays on as executive VP and chief revenue officer. The rest of the piece is unflattering. Market cap is $12 million, the GF Score is 4 out of 100 with financial strength at 1/10, trailing EPS is -2.8, the Altman Z-Score is -11.69, and there has been no insider buying. Price-to-sales is 19.19 against a historical median of about 109. So the after-hours pop the article describes and today's quote point in opposite directions; the article offers no reason for the reversal.
Coherent down 9.6% with two conflicting stories
Coherent is down 9.6%, and the watchlist carries two pieces that disagree. The Investing.com article, published the morning of October 9, explains a 3.5% pre-open rise: Lumentum's CEO said AI data centre demand has booked out its optical component capacity through early 2029, which the market read across to Coherent's own order book and pricing. It cites Coherent's PhotonLink platform launched in September 2026 and a TrendForce forecast of a 650 million unit VCSEL market by 2031 at a 38% CAGR, with Applied Optoelectronics and MaxLinear also higher pre-market. The GuruFocus piece covers the other side, the actual 9.6% fall on October 8 to $302.35, against a GF Value of $102.99, a GF Score of 78/100 with valuation ranked 1/10 and momentum 9/10, a 73.5x P/E versus a 78.0x five-year median, and $1,117 million of insider selling over twelve months with no buying. Worth noting Lumentum itself closed down 5.62% on the quote tables in those same pages.
Astera Labs down 9.2% on a Northland downgrade
Astera Labs fell 9.2%. Northland's Gus Richard cut it to Market Perform from Outperform purely on valuation, with the stock at $347.05 on a P/E of 172. His prior $350 target was built on 50 times a calendar 2028 estimate of $5.00, and he says $5 is achievable but not a given, while expecting estimates to rise over the next couple of quarters as Scorpio-X ramps. The companion Investing.com explainer adds that Zacks had already moved to Hold from Strong Buy the day before, and an October 8 Form 144 flagged a potential insider sale on top of an existing pattern of selling. Context from that piece: Q2 2026 revenue was a record $392.4 million, up 104%, with EPS of $0.80 against $0.69 expected, and Needham had raised its target to $425 from $260. Q3 earnings are due November 3. Separately, Goldman's equal-weight ETF GSEW trimmed 4,862 ALAB shares worth $1.9 million on October 7, part of net selling of $33.6 million that day; the same fund holds ASTS and COHR at 0.21% each.
Nebius down 7.4% ahead of October 22 earnings
Nebius is down 7.4%. Rosenblatt's John McPeek initiated with Buy and a $304 target against a $237.15 close, modelling 4.25 to 4.75 gigawatts of operational compute by 2030 and a 98% revenue CAGR from FY2026 to FY2030. The Investing.com preview frames the October 22 release: Q2 revenue was $582.3 million, up 454%, with AI-cloud revenue up 514%, and the last quarter beat EPS estimates by 80.78% with a 31.99% post-earnings move. The bear side is execution and financing, specifically power connection, equipment and construction delays pushing out payback, against 18.5x forward EV/Sales and 44.3x forward EV/EBITDA. Technically the piece notes price below all daily moving averages but still above the weekly 50, 100 and 200.
Revolution Medicines down 6.3% on FDA subgroup data
Revolution Medicines fell 6.3% after FDA review documents questioned how daraxonrasib, the approved RASONQUE therapy, performs across KRAS mutation subtypes. The numbers: 32% overall response rate, driven by 50% in G12V, versus 24% in G12D, which is the largest cohort at 43% of patients. The FDA stressed the analyses were not designed for formal subgroup comparisons. Four separate pieces here push back. TD Cowen's Tyler Van Buren kept Buy, arguing the 24% G12D figure is close enough to the 31% ITT rate and that PFS and OS hazard ratios are consistent across mutation types, with Zoldon the leading G12D inhibitor in development. RBC kept Outperform and raised its target to $259 from $251. Truist called the dip an entry point. Stifel, cited in the GuruFocus piece, is the one suggesting biology may genuinely limit efficacy in G12D. On the ownership side: no insider buying in twelve months against $149.7 million of insider selling, 109 sales and zero purchases over six months, while 10 gurus hold with 7 adding and 5 trimming. GF Score is 27/100. The stock touched an intraday low of $180.52 against a 52-week low of $47.28, with the next earnings in November.
AST SpaceMobile down 6.1% at the $55 line
ASTS fell 6.1% to close at $56.93 with an intraday low of $55.96 on roughly 19.2 million shares. Both TradingView pieces here are technical and both name the same levels. Robert_V12 had flagged $55 three weeks ago after the $75 rejection and now watches whether buyers defend it, with $50-52 next and $45 then $40-42 if that goes, and $60-65 as the recovery confirmation zone. He ties the pressure to SpaceX agreeing to buy 800 MHz of spectrum from Grain Management, which adds a better-funded competitor in direct-to-device, while arguing the AT&T and Verizon relationships may become more valuable as a result. Tesi_Daniela_Radice adds the operating detail: BlueBird launches 8-10 in June and 11-13 in August, a target of roughly 45 satellites by early 2027, 60-plus operator partners, Q2 2026 revenue of $31.5 million against a $230.9 million net loss including a large non-cash charge, pro forma liquidity above $3.7 billion, and FY2026 guidance of $150-200 million. Two further headline-only items on the list say the same thing about $55 being tested.
SpaceX spectrum deal is the day's shared driver
The SpaceX item is the biggest single cluster on the list and it connects to ASTS and to the telecom names. Headlines only, so taking them at face value: SpaceX is acquiring roughly $8 billion of low-band 800 MHz spectrum to enable Starlink Mobile, Musk posted that it is the last critical piece needed to provide complete phone coverage in America, and US and European telecom stocks sold off, with Deutsche Telekom reported down 7%. Goldman is said to see it as positive for US tower stocks, which rose. SPCX itself is down 4.2%. Other headlines in the group cover Banglalink launching Starlink service in Bangladesh, American Airlines equipping over 1,000 aircraft with Starlink Wi-Fi, Musk criticising Mukesh Ambani over Indian delays, and Trump disclosing SpaceX bond purchases.
Oracle down 5.5% on OpenAI revenue reports and power workarounds
Oracle is down 5.5%, described in one headline as its biggest one-day drop in twelve weeks. The cluster is headline-only but consistent: reports on OpenAI's revenue hit Oracle and Microsoft, analysts warned of revenue risk from project delays, and Oracle is trucking natural gas to power data centres in Utah and Texas to get around pipeline delays, with the same approach possibly extended to a 2.45-GW project. Bloom Energy shares reportedly fell on that gas report. One headline puts Oracle's price at $135.69 against a GF Value of $194.75, and another says Michael Burry has flagged a concern.
The rest of the AI complex lower
Broadcom is down 4.3% with no single explanation in the headlines, though one notes it fell despite TSMC's record AI quarter and another references controversy over circular financing tied to its capital raise. TSMC itself is down 3.0% despite headlines pointing to a record NT$1.49 trillion quarter. Also lower without substance behind the lines here: TeraWulf down 5.2% with calls reportedly outpacing puts four to one, Micron down 4.8%, NuScale down 4.6% at a 52-week low of $7.21, Nokia down 4.5% crossing below its 200-day, Rocket Lab and SPCX in the same Rocket Lab headline, Modine down 4.0%, Credo down 3.7% on a Form 144, and CRISPR down 3.6%.
Gainers are thin and mostly unexplained
VerifyMe is up 10.3%, but the only item attached is a Form 4 filing and the article text is pure site boilerplate with nothing on the filing itself. Marathon Petroleum is up 4.8% alongside headlines on refining and E&P sector leadership. Netflix is up 2.7%, with one headline reporting plans to cut 5% of its workforce per Puck News and another noting Morgan Stanley trimmed its target. Take-Two up 2.6%, Dave up 2.5%, Aflac up 2.0% on a Japan Post share sale, Sezzle up 3.0% on an 8-K with results.
Apple barely moved despite the volume of coverage
Apple is up 1.1% on by far the longest headline list here, which is mostly noise. The items with actual content are a reported cut to iPhone 18 Pro component orders on soft demand per Nikkei, an October 13 "Welcome Home" product event in Tribeca expected to centre on smart home, Steve Smith named head of M&A, an SVP share sale of $796,491, and PC shipments down 20.1% in Q3 with Apple gaining share. Nothing here moved the stock much.
Everything else quiet
The remainder is routine: analyst target tweaks on Amphenol, Axsome, Exelixis, Wheaton and Kodiak Gas, ETF flow reports, Mercury Systems adding 50,000 square feet in Phoenix, a Butterfly Network CEO sale of 35,790 shares, and Costco edging up 0.6% despite September sales reported up 13%. None of it needs a second look today.
The day's shape: AI complex sold off
Almost everything that fell hard on your list fell together, and the backdrop from the Investing.com pages is the same across them: the Nasdaq dropped 1.25% on a report that OpenAI's annualized revenue is less than previously shown, while the Dow finished up 0.10% and the S&P 500 off 0.47%. Oil was the other big mover, WTI up 3.32% around $91 with Brent near $104, and the 10-year sat at 5.22%. So the optics-and-compute names, the neoclouds and the power plays all got hit at once, while the refiner on your list was the best performer of the day. Note that none of the single-stock articles below attributes the drops to company news except where I say so.
Coherent down 9.5% with no stated cause
COHR was the worst mover, down 9.5%. The Yahoo page shows it closing at $302.02, off $32.54 from a $334.56 prior close, with a day's range of $298.89 to $328.87 and volume of 8.37 million against a 6.36 million average. The alert flags it as roughly 1.6 times its own ATR20 on about average volume. Nothing in the three COHR items explains why: the Yahoo page is a quote page, the Investing.com item is a bare Form 4 insider filing notice dated 7 October with no detail attached, and the TradingView post is a chart note watching for a weekly close above a horizontal line. Worth remembering the stock is still up 63.9% year to date and 159% over a year, with a $412.52 average analyst target and a Bernstein initiation at Outperform, $350, on 30 September.
Astera Labs and a Form 144
ALAB fell 9.2%. The only ALAB-specific item with any substance is a Form 144 notice filed 8 October, which is a notice of intent to sell restricted stock. The Investing.com page carries nothing beyond the filing title, so I can't tell you size or seller. The other ALAB item is the same chart-watcher's breakout note, no news content.
Tower Semiconductor and Ur-Energy
TSEM was down 8.4%, closing at $228.59, a $19.66 drop from $248.25, on about 2.05 million shares against a 1.88 million average. Again no reason given in the material. It remains up 89% year to date and 217% over twelve months, with Mizuho having initiated at Outperform with a $300 target on 25 September. URG fell 8.2% to $1.005, which is its 52-week low, and this one is not an AI-selloff story: it's down 27% over a month and 45% over a year, with RBC having maintained Outperform back in August while cutting the target from $1.75 to $1.60. No news item here explains today's move either.
Nebius hit 7.2% despite a new Buy initiation
NBIS fell 7.2% even as Rosenblatt Securities started coverage at Buy with a $304 target, which was about 28% above the $237.15 price at the time. Rosenblatt's case is capacity: Nebius has 3.5GW of contracted power with 75% expected to come online at fully owned sites, putting it roughly one-sixth the size of CoreWeave's 1.5GW of active revenue-generating power. They model Q2 2026 revenue up 5.5 times year over year, full-year 2026 up 6.5 times, and a 98% revenue CAGR through FY2030, with the $304 target built on a ten-year DCF at a 12% discount rate and a 12x terminal free cash flow multiple. They also expect more debt or equity to fund the buildout, after the $5.75 billion convertible in August. Context from the other items: Truist is at Buy with $355, DA Davidson raised to $250 from $175 after the Vineland data center approval, insiders have sold $161.35 million in three months, and the Investing.com preview puts earnings on 22 October, with the bear case resting on capacity delays into H2 2026 and 2027, financing dilution, and 18.5x forward EV/Sales.
Revolution Medicines on an FDA review
RVMD was down 6.3%, and this one does have a clear cause. An FDA review published today questioned daraxonrasib's efficacy across KRAS mutation subtypes, with the regulatory documents noting the underlying analyses were not designed for formal subgroup comparisons. The numbers from GuruFocus: a 32% overall response rate, but 50% in the G12V subgroup versus 24% in G12D, which is the largest cohort at 43% of patients. Stifel points to biological complexity in G12D as a possible explanation. The drug, marketed as RASONQUE, only got its FDA approval for previously treated metastatic pancreatic cancer in late August. Two analysts raised targets into the drop anyway: RBC to $259 from $251 at Outperform, Truist to $240 from $239 at Buy. Insiders have logged 109 sales and no purchases in six months. Intraday low was $180.52.
Vicor and the valuation note
VICR fell 7.2% today. The GuruFocus piece is actually about yesterday's 5.5% decline to $282.78 and is a valuation argument rather than news: GF Value of $71.32 against the market price, a trailing P/E of 90.8x versus a five-year median of 74.2x, and $424.1 million of insider selling over twelve months with no buying. No fresh company event in the material.
Oracle's power workaround and the AI debt pile
ORCL was down 5.9%, described in one headline as its biggest one-day drop in twelve weeks. The headline cluster, which I have not read in full, says Oracle is trucking natural gas to power AI data centers to get around pipeline delays, already doing so in Utah and Texas with the approach possibly extending to its 2.45GW Project, and that Bloom Energy shares fell on that report. Separately, a WSJ-sourced headline has Oracle, Broadcom and SpaceX all pursuing large debt deals to fund the AI buildout, with Broadcom specifically working to arrange more than $50 billion for OpenAI chips. AVGO itself was off 4.4%, with another headline noting Marvell raising the stakes in custom chips. Mizuho added Oracle to its Top Picks list the same day.
SpaceX headlines, mostly Starlink
SPCX fell 4.1% against a heavy run of headlines, all headline-only here: Musk accusing "certain oligarchs" of blocking Starlink's India launch, American Airlines extending Starlink Wi-Fi to its entire mainline fleet of over 1,000 aircraft, Erste Group initiating at hold, a reported $40 billion financing effort with Apollo, and a disclosure that Trump bought SpaceX debt in August.
TSMC fell on strong numbers
TSM was down 3.1% despite headlines reporting September revenue growth of 54.6%, a record Q3 above $46 billion, and a Citi target of NT$4,000. Several of the headlines make the point explicitly, that the sales beat and the share fall happened together.
The green side: refining and a Generac upgrade
MPC was the largest gainer at 4.8%, consistent with the oil move, and the headlines put refining and E&P at the top of the sector leaderboard with Mizuho raising its MPC target to $457. Elsewhere on the plus side, Generac rose 1.0% on a Keybanc upgrade to Overweight with a $280 target and a Piper Sandler initiation at Overweight, $303, with one headline tying it to AI data center demand. Apple added 1.1% ahead of a 13 October "Welcome Home" product event in New York and the appointment of Steve Smith as M&A chief. IOVA was up 3.4% on a Baird target raise to $11, and Netflix gained 2.7% even as Morgan Stanley and Barclays both trimmed targets.
Smaller and quiet names
ASTS fell 6.1%; the only item is a TradingView speculative long note keyed off the $55 to $56 support zone, not news. WULF was down 5.2%, SMR hit a 52-week low of $7.21, RKLB fell 4.6%, and the rest of the list, AAPL ETF-flow items, NIO, APH, COST, AMC and the various single-line analyst notes, carries nothing beyond what the headlines state. One oddity: an item tagged CAN at -6.0% is actually a Walter Bloomberg post quoting CBO's Swagel saying growth alone is unlikely to stabilize the debt trajectory, which has nothing to do with the ticker.
Surf Air down hard against good operating news
Surf Air Mobility was the biggest mover on the list, down 9.6%, and the only news item attached to it reads positively. The company said its SurfOS software helped cut direct operating cost per block hour by 6% and fuel burn per block hour by 9% year-to-date in 2026, with pilot cost per block hour down 9% and labour productivity per block hour up 15%. Q2 ended with a 98% controllable completion factor and 88% on-time arrivals, and Mokulele in Hawaii grew revenue about 7% year over year. It also won a four-year Essential Air Service contract from the DOT covering Lanai through August 2030, worth $19.4 million in subsidies excluding fares and double the term of the prior deal. Other items: 64 demonstration flights of BETA's ALIA CTOL across four Hawaiian islands with Hawaiian Airlines support, joining the FAA's advanced aviation consortium and its airspace trajectory initiative, a Safety Management System finished ahead of the Part 135 deadline, and the Kona–Kahului route relaunched for the first time since 2023. The release gives no explanation for the share move.
Macro backdrop driving the risk-off names
The common thread under most of today's declines is in the Rocket Lab piece, which was explicit that the 4.2% fall had no company-specific cause. It pinned the move on rising Treasury yields, higher oil, and caution ahead of the Fed's September minutes, with the S&P off 0.6%, Dow down 1.0% and Nasdaq down 0.8% intraday. It also noted RKLB had run roughly 17% over the prior month on a record 20-launch Electron contract with Japan's Synspective and a Citi Buy with a $105 target, so part of this is consolidation after a strong run, with execution demands across the Iridium acquisition and Neutron development still ahead. Sector sentiment was further weighed by reports SpaceX is seeking a $40 billion financing package. On the geopolitics, two Walter Bloomberg posts relaying a senior Iranian official to Reuters said Iran will never give up its right to enrich though enrichment details can be discussed later, and that there have been no negotiations with the US, with Tehran's conditions needing to be met first. Separately, Italy's economy minister asked the EU to treat inflation as a factor justifying deviation from budget goals. Those three X items carry a -4.4% quote tag against the ticker CAN, which looks like a tagging artefact rather than a reaction in that name.
The GuruFocus overvaluation template across five holdings
A cluster of automated GuruFocus pieces hit five of your names with the same structure, so read them as one screen output rather than five independent views. Navitas was down 5.6%, with the article citing a 3.0% decline to $11.97 against a GF Value of $2.99, a GF Score of 63, momentum ranked 8/10 and valuation 1/10, and $150.7 million of insider selling over twelve months with no buying. Vicor fell 5.5% to $282.78 versus a GF Value of $71.32, GF Score 79, trailing P/E of 90.8x against a five-year median of 74.2x, and $424.1 million of insider sales with no purchases. Rocket Lab, down 4.2% at $71.92, carries a GF Value of $38.89, a score of 71 with growth at 10/10 and valuation at 1/10, and $683.3 million of insider selling. TeraWulf fell 3.8% to $14.40 against a GF Value of $5.86, with the weakest scorecard of the group at 39/100 and net insider selling of $35.6 million. Anglogold Ashanti (down 3.7%) and Mercury Systems (also down 3.7%) appear as headline-only versions of the same template, quoting GF Value of $65.85 against $90.05 and $48.60 against $79.75 respectively.
Nebius slides on a buy initiation
Nebius was down 5.1% on the day Rosenblatt Securities started coverage at buy with a $304 target, about 28% above the $237.15 price. Rosenblatt places Nebius near the top of the neocloud group alongside CoreWeave, estimating its active revenue-generating power at roughly one-sixth of CoreWeave's 1.5GW, with 3.5GW contracted and 75% expected to come online at fully owned sites. Q2 2026 revenue was up 5.5 times year over year, full-year 2026 is expected up 6.5 times, and the firm models a 98% revenue CAGR through FY2030, with the target built off a ten-year DCF at a 12% discount rate and a 12x terminal FCF multiple. It expects more debt or equity to fund capacity, after August's $5.75 billion convertible. The same piece lists Truist initiating at buy with a $355 target, DA Davidson lifting to $250 from $175 on the Vineland data centre approval while keeping a Neutral, a planned $4.5 billion convertible note offering due 2030 and 2034, and October price rises on on-demand H100, H200, B200 and B300 GPU capacity. A separate GuruFocus daily brief flags COO Ophir Nave selling 500,000 shares at $235.53, about $117.8 million, on 6 October.
Micron up on conflicting inputs
Micron rose 4.1% to $1,088, the largest gainer here, and the four items on it pull in different directions. DA Davidson raised its price target to $3,000 from $2,100, citing memory demand from AI accelerators and data centres, though the stock was actually down 2.6% premarket at $1,018 when that piece ran. Against that, union members at Micron's Taiwan operation voted 99% in favour of authorising a strike over bonus structure, demanding a permanent profit-sharing plan allocating 15% of operating profits to quarterly bonuses, which comes with memory prices already climbing on supply shortage. The GuruFocus valuation note gives Micron a GF Score of 90 with growth 10/10 and profitability 9/10, a trailing P/E of 14.7x versus a five-year median of 20.7x, but a GF Value of $764.61 against the market price, and net insider selling of $373.2 million. ETFs were net sellers of $97.0 million on 5 October, led by SPY at $66.1 million, QQQ $57.7 million and IVV $45.3 million, though 43 funds bought versus 24 sold. Trailing twelve-month revenue is given as $133.19 billion, up 250.7%, with the stock up 266.55% year to date.
Brazilian financials downgraded by HSBC
Itau Unibanco fell 4.0% after HSBC's Carlos Gomez-Lopez cut it from Buy to Hold with a $9.10 target against a $9.74 price. The accompanying GuruFocus data puts GF Value at $5.48, a GF Score of 70 with profitability and growth both 8/10 but financial strength at 2/10 and valuation 1/10, a P/E of 13.13x versus a five-year median of 7.9x, a 5.84% dividend yield, and $1.12 million of insider selling over three months. Bradesco, down 3.8%, has a headline-only item saying HSBC also downgraded it with a $3.90 target, so this looks like a single HSBC sector action rather than two separate calls. Separately, a headline notes Itau BBA upgraded XP to Outperform.
NetApp upgraded
NetApp was up 3.2% on a cluster of headline-only items all pointing at the same thing: Evercore ISI upgraded the stock with a price target raised to $300, cited as based on the FY27 growth outlook. Investor's Business Daily and Investing.com both carried it, and a GuruFocus headline asks whether the stock is overvalued after the rally.
SpaceX and the AI debt wave
SpaceX was down 2.5% with by far the heaviest headline flow of any name here, though none of it was read in full. The dominant story is a reported $40 billion financing effort, led by Apollo Global Management per one headline, to fund Nvidia chip purchases for computing infrastructure, first reported by the FT. Susquehanna raised its target to $173 from $144. There is a parallel set of Musk posts on Starlink: availability in Bangladesh, accusations that "certain oligarchs" are blocking the India launch, a denial that Starlink beams were used over India since they are turned off there, and claims that V2 direct-to-cell satellites will carry over 100 times the bandwidth of V1. Other headlines cover a 32-mile Florida natural gas pipeline application, Cathie Wood trimming the position, Musk saying TSMC will not be involved in operating the Texas Terafab, and a reported science medal from Trump. This connects to Broadcom, up 0.2%, where headlines say it is arranging more than $50 billion tied to the OpenAI chip programme, and Oracle, down 0.8%, with the WSJ reporting all three chasing large debt deals to fund AI buildout. Oracle separately appears on Mizuho's Top Picks list and drew an In Line initiation from Yorkville's Dan Ives on execution risk.
TSMC and the rest of semis
TSMC fell 2.1% despite headlines saying it beat its September sales target with revenue up 54.6% and posted record Q3 revenue above $46 billion, with Citi raising its target and projecting over 40% revenue growth by 2027. Elsewhere in chips, Astera Labs was down 1.9% with a Form 144 filing and an unread "why is it sliding" piece, Sandisk was up 1.9%, Amphenol down 1.2% with UBS raising its target to $105 and a leadership change in its harsh environment division, and Coherent down 1.1%.
Quieter names
Apple rose 0.9% amid heavy but low-content ETF flow coverage, plus headlines on a European Commission proposal to tax large US tech firms, a smart home launch with LG, and a $400 target tied to Siri. Elsewhere: TD Synnex, down 2.5%, agreed to acquire specialty distributor BlueStar; Generac, down 1.0%, was upgraded to Overweight by KeyBanc with a $280 target and initiated Overweight at Piper Sandler, alongside an insider sale; SoundHound, down 1.6%, hit a 52-week low at $5.64; Datadog, Netflix, Aflac, Costco, Joby and Credo all carry routine analyst or filing items with moves under 2.5% and nothing substantive behind them.
Surf Air leads the downside despite good news
Surf Air Mobility is down 9.9%, which sits oddly against what it actually announced. The company said SurfOS software drove a 6% cut in direct operating cost per block hour and a 9% cut in fuel burn per block hour year to date in 2026, plus a 9% drop in pilot cost per block hour and a 15% gain in labour productivity. Q2 ended with a 98% controllable completion factor and 88% on-time arrivals, and Mokulele in Hawaii grew revenue about 7% year over year. It also won a four-year Essential Air Service contract from the DOT covering Lanai through August 2030, worth $19.4 million in subsidies excluding fares, double the term of the prior deal. Other items: 64 demonstration flights with BETA Technologies' ALIA CTOL aircraft across four Hawaiian islands with Hawaiian Airlines' support, first Part 135 passenger operator into the FAA's Center for Advanced Aviation Technologies Consortium, a Safety Management System implemented ahead of the FAA deadline, and Kona–Kahului service relaunched for the first time since 2023. The article gives no reason for the share price fall.
BeyondSpring 8-K
BeyondSpring is down 8.9% with an 8-K on EDGAR reporting completion of an acquisition or disposition of assets. Headline only, so no detail on what was bought or sold.
Navitas closes Claros, shares fall anyway
Navitas is down 5.8% on the day it confirmed closing the Claros acquisition. Claros builds integrated voltage regulator technology for AI data centres, combining power transistors, digital control, inductors and capacitors, with a PowerArray architecture meant to move power conversion closer to the processor. Navitas says the deal takes its serviceable addressable market past $8 billion by 2030, adding at least $3.5 billion from vertical power delivery and IVR on top of its existing $3.5 billion GaN and SiC base and roughly $1 billion from JFET. CEO Chris Allexandre called it a defining step in the "Navitas 2.0" transformation. A webinar on the technology is set for 20 October. A separate 8-K (Reg FD, Other Events) and a GuruFocus piece on the same acquisition round out the cluster, along with a GF Score note. Again, nothing in the material explains the drop.
Nebius down with insider selling and chart chatter
Nebius is off 5.1%. Two GuruFocus headlines say COO Ophir Nave sold 500,000 shares on 5 October, described as nearly half his holding. The rest of the NBIS flow is retail chart commentary on TradingView rather than news: one poster expects a retrace but not below $205, another says he went short despite a clean upside break of the consolidation because momentum and volume lagged, and a third thinks $250 resistance is likely to give way. Treat these as opinion, not information.
A PL tagging problem
The ticker PL is down 4.4%, but the full-text item filed against it is an earnings call for Progressive Planet Solutions (PLAN), a different company, not Planet Labs. For what it's worth, Progressive Planet posted record fiscal Q1 2027 revenue of CAD 7.3 million, up 12.1% from CAD 6.51 million, with roughly 400 basis points of margin compression from freight, diesel and packaging inflation. Freight alone rose 50.5% to CAD 1.233 million. CEO Stephen Harpur said he doesn't expect meaningful margin improvement over the next six to twelve months. The only genuine Planet Labs item is a GuruFocus GF Score note referencing a 7.0% share surge, which conflicts with today's quote.
Macro headlines mistagged to CAN
CAN shows down 4.3%, but the items under it are macro wire posts, not company news. A senior Iranian official told Reuters that Iran will never give up its right to enrich though enrichment details can be discussed later, and separately that there have been no negotiations with the US and that Washington must meet Tehran's conditions first. Italy's economy minister asked the EU to treat inflation as a factor justifying deviation from budget goals. A headline-only item has Zelenskiy citing updated intelligence that Russia is preparing a massive attack. Relevant to oil and yields, not to CAN itself.
Rocket Lab, ITUB, VEEA
Rocket Lab is down 4.2%, with Investing.com running a "why is the stock sliding today" piece and a bearish TradingView head-and-shoulders post, both headline only. Itau BBA upgraded XP to Outperform from Market Perform, per a headline tagged to ITUB, which is down 4.3%. Veea has an 8-K with only an Other Events item, down 4.3%.
Micron up on mixed news
Micron is up 4.0%, the biggest gainer on the list. The headlines are a mix: DA Davidson raised its price target while the stock dipped premarket, Micron's Taiwan union voted to authorise a strike over bonus structure, ETFs were net sellers on 5 October, and Netlist surged 18% on a $600 million licensing deal with Micron. All headline only.
NetApp upgrade cluster
NetApp is up 3.3% on a clear analyst cluster. Evercore ISI upgraded the stock and raised its target to $300, citing a strong FY27 growth outlook per the headlines, and TD Cowen kept its rating with a target raised to $250. Investor's Business Daily also flagged the upgrade after a big rally. All headline only, but the direction of the notes is consistent.
SpaceX dominates volume, down on the debt story
SpaceX is down 2.5% and accounts for the largest single block of items here. The driver, reported first by the FT and repeated across a dozen outlets, is a plan to raise around $40 billion in financing led by Apollo Global Management to buy Nvidia chips. One wire post notes shares fell 1.5% on that report, and Investing.com's premarket movers piece names SpaceX debt plans as a weight on the tape. Alongside it: Susquehanna raised its target to $173 from $144, Goldman Sachs also lifted its target, Morgan Stanley weighed in, Cathie Wood trimmed the position, and Musk clarified SpaceX's role in the TSMC Terafab project without a deal in place, which a separate headline links to TSMC weakness. Musk also posted on Starlink in India, V2 direct-to-cell satellites claiming over 100 times the bandwidth of V1, and Grok routing to third-party models including Claude Opus 5.5. All of this is headline level.
Semis and the rest
TSMC is down 1.9% with Citi and Barclays both raising targets, Barclays to $665, and headlines on a $100 billion capex expansion and four new US fabs, none of which were read in full. SanDisk is up 1.9% with a target raised to $2050. Astera Labs is down 1.8%, Coherent down 1.0%, both with "why is the stock sliding" pieces that are headline only. BWXT is down 2.8% despite headlines about a new microreactor project and a 7.5% rise; Truist lowered its target to $182. TD Synnex, down 2.6%, agreed to acquire specialty distributor BlueStar. Aflac has five separate broker notes pointing in different directions and is down 1.0%.
Quiet names
Apple is up 0.9% with heavy but low-substance flow: smart home launch on 13 October with an LG partnership, App Store revenue growth UBS isn't ready to call a turnaround, an EU tech tax proposal, and a long run of ETF flow notes. Broadcom, Oracle, Netflix, Costco and the smaller names are all within a point either way and carry nothing beyond routine broker notes, ETF flow tallies and chart posts.
Veea down hard despite new deployment deal
VEEA is the worst mover on the list, down 13.6%, and there are two items against it. The one I read is a GuruFocus piece on a one-year partnership announced 6 October with La Estadia, a community of 220 residential properties, to put Veea's SecureConnect platform and its Veea Vision edge-based AI video analytics into the community's network. The rest of that article is valuation and scoring commentary rather than news: market cap around $18 million, price-to-sales of 28.3 against a historical median near 109x, GF Score of 4 out of 100, financial strength rated 1 out of 10, an Altman Z-Score of -11.61, no insider buying or selling in twelve months, no guru holders. Nothing in that article explains the drop. Separately there's an 8-K filed under Item 8.01, Other Events, which I have only as a headline, so if you want the reason for the move that filing is the first place to look.
Surf Air up on DOT contract and cost metrics
SRFM is up 13.4% after a press release covering both operating improvements and a new four-year Essential Air Service contract from the Department of Transportation. The contract extends service to Lanai through August 2030, is worth $19.4 million in subsidies excluding fare revenue, and doubles the term of the previous agreement. On operations, the company credits its SurfOS software with a 6% cut in direct operating cost per block hour year to date in 2026, a 9% cut in fuel burn per block hour, a 9% cut in pilot cost per block hour and a 15% gain in labour productivity per block hour. Q2 ended with a 98% controllable completion factor and 88% on-time arrivals, and Mokulele, the Hawaii operation, grew revenue about 7% year over year. The release also covers 64 demonstration flights of BETA Technologies' ALIA CTOL aircraft across four Hawaiian islands with Hawaiian Airlines' support, membership of the FAA-sponsored advanced aviation consortium as the first Part 135 passenger operator, a completed Safety Management System rollout ahead of the FAA deadline, and the relaunch of Kona to Kahului service for the first time since 2023.
BeyondSpring filing, no detail
BYSI is down 11.9% with only an 8-K headline behind it, filed under Item 2.01, completion of an acquisition or disposition of assets, plus financial statements. I have the headline only, so nothing on what was bought or sold.
AST SpaceMobile up 8% with no stated catalyst
ASTS rose 8.0% to $63.11, and neither of the two full-text pieces identifies a reason. Both are GuruFocus valuation write-ups. The stock sits in a 52-week range of $49.31 to $133.86, is down 13.1% year to date and 13.4% over a year despite the day's gain. GF Value is put at $571.18 against the current price, which the article itself flags as a possible value trap given the company is unprofitable and cash-flow negative with an operating margin worse than -400%. GF Score is 44 out of 100, profitability 1 out of 10, growth 0, momentum 7. Price-to-sales is 155.6 against a historical median near 62x, market cap $18.7 billion. The detail worth your attention is insider activity: $451.6 million of insider selling over twelve months against $0.8 million of buying, while six tracked gurus hold the stock, five adding and two trimming. The second article is a sector piece naming ASTS among 15 communication services growth names with an A+ growth grade, alongside NIQ Global Intelligence and Reddit.
BWXT jumps on New Brunswick microreactor win
BWXT is up 7.6%, closing at $145.70 on volume 1.6 times its 20-day average and a move of 2.1 times its own ATR20. The driver is named: BWXT's BANR microreactor technology was selected for a transportable nuclear power plant in New Brunswick, a 50 MW electric facility with Prodigy Clean Energy and two First Nations communities, targeted for early-2030s operation. Cutting the other way on the same day, Truist Securities kept a Hold and lowered its target to $182 from $202, a 9.9% reduction. The valuation pieces put GF Value at $156.77, GF Score at 92 out of 100 with growth and valuation both 10 out of 10 and momentum 4, trailing P/E of 37.7 against a five-year median of 32.5, forward P/E 27.8. Insiders sold $9.0 million over twelve months with no buying, including $1,725,000 in the last three months, and of nine tracked gurus two added while eight trimmed. Note the stock is still down 15.3% year to date and 23.4% over a year even after this bounce, and the Yahoo page shows it giving back 2.17% pre-market.
Astera Labs on S&P 500 inclusion speculation
ALAB is up 7.6%, the most-covered name on the list with five full reads. Investing.com attributes the move to traders positioning for S&P 500 inclusion at the next quarterly rebalance: passive funds account for roughly 30% of assets tracking the index, ALAB's market cap near $47.6 billion clears the $22.7 billion minimum, and Fubon recently started coverage with a Buy and a $500 target. The fundamentals cited alongside: Q2 revenue of $392.4 million, more than double a year earlier and above the $360.7 million consensus, adjusted EPS of $0.80 against $0.69 expected, and Q3 guidance of $540 to $560 million at a 72% gross margin and 43% operating margin, roughly 40% sequential growth, with Scorpio X AI fabric switches in volume production ahead of schedule and PCIe 6.0 past 50% of quarterly revenue. The stock had been more than 36% off its $499.48 record before this rally. Two counterweights in the same pile: a GuruFocus flow piece showing three straight days of net ETF selling, $16.4 million on 2 October with SOXX alone out $12.6 million, and the WarrenAI ranking, which puts ALAB second behind Credo on the grounds that InvestingPro Fair Value of $230.05 implies 40.6% downside even though revenue growth was 98.5% at a 75.1% gross margin. ALAB also appears in the IBD futures piece as one of six AI names leading buys alongside GE Vernova and Arista, and in a TradingView chart post. Credo, in the same WarrenAI ranking and up 3.9% today, is placed first on 165.1% revenue growth, 67.1% gross margin and a $232.44 fair value; there's also a Form 4 headline on Credo.
Nokia up 7.5% on CEO's AI supply comments
NOK gained 7.5% to $10.97 on volume roughly in line with its 20-day average. CEO Justin Hotard said the AI buildout is supply-constrained rather than demand-constrained, that customers would probably build data centres twice as fast if they could, and that even with no new frontier model for three years the industry could make large progress deploying what exists. The numbers behind it: Q2 AI and cloud order intake of €2.8 billion with sales to those customers more than doubling year over year, about half of those orders expected to convert to revenue within twelve months, Network Infrastructure sales up 12% with Optical up 20% and IP up 16%, and full-year comparable operating profit guided to €2.1 to €2.6 billion. Q3 results are due 22 October. The stock has run roughly 121% over a year and the GuruFocus valuation piece calls it 117% overvalued against a GF Value of $5.05, with a trailing P/E of 75.7 versus a five-year median of 21.6, GF Score 65, momentum 9 out of 10 but valuation 1 out of 10. Two further Nokia headlines cover the same CEO remarks.
Nebius insider sales alongside a 7.4% gain
NBIS is up 7.4% with seven headline-only items, and the theme is split. Two headlines report COO Ophir Nave selling 500,000 shares, described as nearly half his holding, on 5 October, and a third says Nebius executives sold $19 million of stock. Against that, one headline has the stock pushing past $250 resistance on strong volume, and three TradingView posts debate whether the breakout holds. I only have the headlines here, so take the insider figures as stated and nothing more.
Other sizeable moves, headline detail only
BFLY is down 7.2% while the only item on it is an Investing.com headline saying the stock hit a 52-week high at $10.05, so the two don't line up and it's worth a look. DAVE fell 7.0% and PL rose 7.0%, both with GuruFocus valuation-score headlines only; note the two PL earnings items are about Progressive Planet, a different company, not Planet Labs. CRSP is down 5.8% with a Form 144 filing headline. AMC is up 5.7% on an 8-K covering a new material agreement, termination of another, a new direct financial obligation and Reg FD disclosure, which reads like a financing or refinancing, though I only have the item list, not the content. RVMD fell 3.8% and appears in an IBD piece on biotech selling off, with Vaxcyte, Moderna and Revolution Medicines among the biggest losers. NVTS is down 3.0% on the day it completed its acquisition of power management firm Claros, with an accompanying 8-K.
Analyst actions across the smaller holdings
A cluster of rating changes, all headline-only. Upgrades: JP Morgan to Overweight on BBD, up 4.2%; Itau BBA to Outperform on XP with a $27 target, filed under ITUB, up 2.3%; Evercore ISI upgrading NetApp on its growth outlook with the target to $300, NTAP up 2.1%, with TD Cowen also lifting NTAP to $250. Baird started Modine at a $300 target, MOD up 3.8%. Elsewhere, Guggenheim assumed Xenon with a Buy and $73 target even as the stock hit a 52-week low and fell 2.7%, TD Cowen cut targets on PGY to $25 and SEZL to $160, SanDisk had its Outperform target raised to $2,050 while slipping 2.6%, UBS raised Aflac to $125, Goldman raised Amphenol to $116 on a day APH hit an all-time high and rose 1.5%, and on Netflix, up 1.8%, there's a StoneX Hold ahead of earnings and a Goldman target cut to $90 on engagement concerns. GLJ Research started Vertiv at Sell.
Broadcom and the AAPL/SPCX flow noise
AVGO rose 3.7% with a large block of items, mostly ETF flow tallies and chart posts, plus Investing.com and GuruFocus pieces on why it rallied and a note that Cathie Wood bought $13 million of stock. I have headlines only on all of them, so I can't tell you what the stated reason was. Apple, up 0.2%, and SpaceX, up 0.5%, between them account for a large share of the list, and almost all of it is ETF buy/sell tallies, TradingView chart commentary and repeated coverage of the same two stories: SpaceX seeking $40 billion in Apollo-led financing to buy Nvidia chips, and Apple's App Store growth staying weak with UBS at Neutral and a $296 target. Tim Cook sold $63.8 million of stock per a Form 4 headline. Micron is down 1.7% with headlines on a Taiwan union strike authorisation over bonus structure and a $600 million Netlist licensing deal. Nothing else in the tail moved enough to need you.
Veea down hard on a partnership announcement
VEEA is the worst mover on the list, down 13.6%, and the only news behind it is a positive one: a one-year deal announced October 6 with La Estadia, a community of 220 residential properties, to put Veea's SecureConnect platform and its Veea Vision edge-AI video analytics into the community's network. The GuruFocus piece spends most of its length on the balance sheet rather than the deal. Market cap is $18 million, price-to-sales is 28.3 against a historical median near 109x, the company is unprofitable so P/E doesn't apply, and the GF Score is 4 out of 100 with financial strength at 1/10 and an Altman Z-Score of -11.61. No guru holdings, no insider buying or selling in the past twelve months. The article does not explain today's drop.
Iovance 8-K
IOVA is down 8.4% with an 8-K filed under Item 8.01 (Other Events). That's headline only, so the contents aren't known from here. Given the size of the move against a filing that could say anything, this is the one worth opening yourself.
AST SpaceMobile up 8% despite a cut estimate
ASTS rose 8.0%, and the news flow is mixed. William Blair kept a Market Perform rating but cut its 2027 revenue estimate to $459 million from $752 million, blaming a slower launch cadence for the BlueBird II satellites and shipment delays. The firm now assumes fewer than 20 satellites in orbit by end-2026, against the company's own start-of-year expectation of at least 45. BlueBirds 14, 15 and 16 have shipped to Cape Canaveral, so another launch could come in the next few months, and Abel Avellan says BlueBird 11 is fully deployed with all 13 satellites performing. The offsetting item is the first completed integration test with TELUS, linking TELUS's wireless network to the satellite constellation for direct-to-phone data, voice and text, with service to TELUS customers expected within a year. Context from the same articles: Q2 showed adjusted EPS of -$0.77 against -$0.26 expected and revenue of $31.52 million versus $35.18 million expected, though sales more than doubled sequentially. B. Riley cut to Neutral with a $65 target from $85, Berenberg started at Buy with $92, Cantor raised to $90 at Overweight. Insiders have sold $451.6 million over twelve months against $0.8 million bought. ASTS also appeared on a GuruFocus list of communication services growth names with an A+ growth grade, at 155x sales versus a 62x historical median.
Astera Labs and the S&P 500 inclusion trade
ALAB is up 7.6% and there's an actual stated reason: traders positioning for inclusion in the S&P 500 at the next quarterly rebalance. Market cap near $47.6 billion clears the $22.7 billion minimum, passive funds are roughly 30% of assets tracking the index, and analysts have named it a top candidate. Fubon also initiated at Buy with a $500 target. The fundamentals behind it: Q2 revenue of $392.4 million, more than double a year ago and ahead of the $360.7 million expected, adjusted EPS of $0.80 versus $0.69, and Q3 guidance of $540-560 million at 72% gross margin and 43% operating margin. Scorpio X AI fabric switches are in volume production ahead of schedule and PCIe 6.0 products have passed 50% of quarterly revenue. The stock had been more than 36% off its $499.48 record before this rally. Two counterweights in the same batch: ETFs were net sellers of $16.4 million on Friday, a third straight day of outflows after $13.4 million Thursday and $17.7 million Wednesday, led by SOXX at $12.6 million and QQQ at $4.3 million. And a WarrenAI ranking put Credo first ahead of Astera and Marvell, flagging Astera's InvestingPro Fair Value at $230.05, implying 40.6% downside, against 98.5% revenue growth and 75.1% gross margin. A TradingView post argued against chasing the $400 gap and favoured a retest near $378.
Credo alongside Astera in the same networking ranking
CRDO is up 3.9% and sits at the top of that same WarrenAI list, with 165.1% revenue growth, 67.1% gross margin, debt to capital of 0.1%, Fair Value of $232.44 and an analyst target of $279.09. The piece noted optical DSPs, silicon photonics and ZeroFlap Optics were each expected to top $100 million of revenue in fiscal 2027. Separately and headline-only, Stifel lowered its Credo target to $310 and chief legal officer James Laufman sold 5,000 shares.
Nebius up 7.4% on a technical break
NBIS rose 7.4%, with GuruFocus describing a roughly 9% jump to around $253.25 that cleared the $250 resistance level on about 11.55 million shares by midday, with MACD positive and RSI near 70. It trades at 51.84x sales versus a 6.98x historical median, GF Score 52 with momentum at 9/10 and valuation at 2/10. Two days earlier the stock was down 3% to $235.00 when it announced the acquisition of inference optimizer Inferize, folded into Nebius Token Factory, with no price disclosed and no utilization target or savings figure given. That same piece noted Michael Burry had added to a bearish position ahead of an expected semiconductor downturn. On insiders, executives sold $19.07 million of shares at $234.16 to cover taxes on vested RSUs: Volozh about $8.85 million, Korolenko about $6.81 million, Shtan about $3.41 million, all filed as automatic rather than discretionary, with large positions retained. Twelve-month insider selling totals roughly $199 million. Quarterly revenue was $582.3 million, up 454% year over year, and the company signed a 12-year deal for 50 megawatts of AI data-centre capacity. Two TradingView posts take opposite sides, one looking for a retrace not below $205, another short on weak volume behind the breakout.
Butterfly Network hit a 52-week high and then fell
BFLY is down 7.2% despite an Investing.com piece noting it touched a 52-week high at $10.05, trading $10.15 for a $2.66 billion market cap and up 292.2% over a year. Q2 showed adjusted EPS of -$0.01 against -$0.04 expected but revenue of $15.72 million versus $29.15 million expected, with the company pointing to record margins and higher US sales and raising full-year guidance. Evercore ISI started at Outperform with a $15 target, Needham at Buy with $10. Separately there's an 8-K under Item 5.02, covering a departure or appointment of officers or directors, which is headline only here and is the likelier thing behind today's drop.
AMC financing 8-K
AMC is up 6.1% on an 8-K covering entry into a material definitive agreement, termination of another, and creation of a direct financial obligation, plus Reg FD disclosure. Headline only, but the item list points to a refinancing of some kind.
Broadcom rally with several threads
AVGO is up 3.7% and there are a dozen headlines on it, none read in full. The ones with actual content in the headline: the FT reporting Wall Street testing lender appetite for a $60 billion Broadcom-Anthropic deal, Cathie Wood buying $13 million of stock, net ETF buying of $373.5 million on October 2, UBS adjusting its TPU model on v10 design changes, and a GuruFocus piece saying power bottlenecks leave forecasts intact. A DCF item puts intrinsic value at $225 against a $355 price.
Revolution Medicines and the biotech selloff
RVMD is down 3.8%, and an IBD headline frames it as part of a broader biotech pullback hitting recent winners including Moderna and Vaxcyte. The company separately began a phase 3 pancreatic cancer trial. Both headline only.
Smaller analyst and insider items
Kodiak Gas Services is up 4.4%, with Barclays lowering its target to $67 and a Form 144 filed. Generac is up 3.9% with Cantor Fitzgerald cutting its target to $297, described in the headline as a valuation reset. On Holding is up 4.0% on a GuruFocus GF Score note. Xenon hit a 52-week low and is down 2.7%, while Guggenheim assumed coverage at Buy with a $73 target. SanDisk is down 2.6% and testing support near $1,670, with a separate Outperform reiteration at a $2,050 target. NetApp is up 2.1% on a TD Cowen target raise to $250, with CEO George Kurian selling 10,000 shares and director Gerald Held 5,757. Vicor is down 2.1% with the CEO selling $6.3 million and a VP selling 3,072 shares. Pagaya is down 1.9% after TD Cowen cut to $25, alongside a closed $600 million AAA-rated ABS deal.
Netflix, Oracle and the rest, quiet
The remaining names moved little. Netflix is up 1.8% with a cluster of pre-earnings notes: Goldman lowered its target to $90 on engagement concerns, TD Cowen reiterated at $100, StoneX kept Hold. Oracle is up 1.6% on a mix of a health data breach affecting nearly 20 million people, a $10 million donation to the Nashville Symphony, and insider buying of about $3.5 million. Amphenol hit an all-time high and is up 1.6%, with Goldman raising to $116. TSMC is down 0.7% despite a heavy news flow around Terafab talks with Musk that Musk confirmed without a deal, plus a Barclays target raise to $665. SpaceX is up only 0.5% across roughly thirty headlines covering a proposed 32-mile Florida gas pipeline for Starship, a Goldman target hike and Morgan Stanley's Overweight. Apple is flat at +0.2% under a long list of ETF flow items and insider sales including Tim Cook's $63.8 million. Everything else here, Joby, Vertiv, Marathon, Costco, TeraWulf, Si-Bone, Aflac, is routine filings and broker notes with no meaningful move.
TradingView
Trading 212
